Shan Lin

机构：North Sichuan Medical University, Beijing University of Chinese Medicine, Affiliated Hospital of North Sichuan Medical College

发表论文 62 篇 · 总被引 1249 次 · h-index 21

代表论文

• ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials (2020 · Drugs · 被引 184)
• Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis (2023 · Frontiers in Immunology · 被引 35)
• Automated fire risk assessment and mitigation in building blueprints using computer vision and deep generative models (2024 · Advanced Engineering Informatics · 被引 32)
• Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis (2021 · Translational Cancer Research · 被引 30)
• Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis (2021 · Cardiovascular Drugs and Therapy · 被引 27)
• Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis (2022 · Frontiers in Medicine · 被引 19)